Global and United States Biopharmaceutical Cmo & Cro Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Sep-2020
No. of pages: 145
Inquire Before Buying

Biopharmaceutical Cmo & Cro market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Cmo & Cro market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Biopharmaceutical Cmo & Cro market is segmented into

- Biologics

- Biosimilars

Segment by Application, the Biopharmaceutical Cmo & Cro market is segmented into

- Contract Manufacturing

- Contract Research

Regional and Country-level Analysis

The Biopharmaceutical Cmo & Cro market is analysed and market size information is provided by regions (countries).

The key regions covered in the Biopharmaceutical Cmo & Cro market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Biopharmaceutical Cmo & Cro Market Share Analysis

Biopharmaceutical Cmo & Cro market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biopharmaceutical Cmo & Cro business, the date to enter into the Biopharmaceutical Cmo & Cro market, Biopharmaceutical Cmo & Cro product introduction, recent developments, etc.

The major vendors covered:

- Lonza

- Boehringer Ingelheim GmbH

- Rentschler Biotechnologie GmbH

- Inno Biologics Sdn Bhd

- JRS Pharma (Celonic GmbH)

- BIOMEVA GmbH

- ProBioGen

- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

- TOYOBO CO., LTD

- Samsung BioLogics

- Patheon

- CMC Biologics

- Binex Co., Ltd.

- AbbVie Inc.

- WuXi Biologics.

Global and United States Biopharmaceutical Cmo & Cro Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Biopharmaceutical Cmo & Cro Product Introduction
1.2 Market Segments
1.3 Key Biopharmaceutical Cmo & Cro Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biopharmaceutical Cmo & Cro Market Size Growth Rate by Type
1.4.2 Biologics
1.4.3 Biosimilars
1.5 Market by Application
1.5.1 Global Biopharmaceutical Cmo & Cro Market Size Growth Rate by Application
1.5.2 Contract Manufacturing
1.5.3 Contract Research
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biopharmaceutical Cmo & Cro Market Size, Estimates and Forecasts
2.1.1 Global Biopharmaceutical Cmo & Cro Revenue 2015-2026
2.1.2 Global Biopharmaceutical Cmo & Cro Sales 2015-2026
2.2 Global Biopharmaceutical Cmo & Cro, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Biopharmaceutical Cmo & Cro Historical Market Size by Region (2015-2020)
2.3.1 Global Biopharmaceutical Cmo & Cro Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Biopharmaceutical Cmo & Cro Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Biopharmaceutical Cmo & Cro Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Biopharmaceutical Cmo & Cro Sales Forecast by Region (2021-2026)
2.4.2 Global Biopharmaceutical Cmo & Cro Revenue Forecast by Region (2021-2026)
3 Global Biopharmaceutical Cmo & Cro Competitor Landscape by Players
3.1 Global Top Biopharmaceutical Cmo & Cro Sales by Manufacturers
3.1.1 Global Biopharmaceutical Cmo & Cro Sales by Manufacturers (2015-2020)
3.1.2 Global Biopharmaceutical Cmo & Cro Sales Market Share by Manufacturers (2015-2020)
3.2 Global Biopharmaceutical Cmo & Cro Manufacturers by Revenue
3.2.1 Global Biopharmaceutical Cmo & Cro Revenue by Manufacturers (2015-2020)
3.2.2 Global Biopharmaceutical Cmo & Cro Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biopharmaceutical Cmo & Cro Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biopharmaceutical Cmo & Cro Revenue in 2019
3.2.5 Global Biopharmaceutical Cmo & Cro Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biopharmaceutical Cmo & Cro Price by Manufacturers
3.4 Global Biopharmaceutical Cmo & Cro Manufacturing Base Distribution, Product Types
3.4.1 Biopharmaceutical Cmo & Cro Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biopharmaceutical Cmo & Cro Product Type
3.4.3 Date of International Manufacturers Enter into Biopharmaceutical Cmo & Cro Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biopharmaceutical Cmo & Cro Market Size by Type (2015-2020)
4.1.1 Global Biopharmaceutical Cmo & Cro Sales by Type (2015-2020)
4.1.2 Global Biopharmaceutical Cmo & Cro Revenue by Type (2015-2020)
4.1.3 Biopharmaceutical Cmo & Cro Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biopharmaceutical Cmo & Cro Market Size Forecast by Type (2021-2026)
4.2.1 Global Biopharmaceutical Cmo & Cro Sales Forecast by Type (2021-2026)
4.2.2 Global Biopharmaceutical Cmo & Cro Revenue Forecast by Type (2021-2026)
4.2.3 Biopharmaceutical Cmo & Cro Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biopharmaceutical Cmo & Cro Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biopharmaceutical Cmo & Cro Market Size by Application (2015-2020)
5.1.1 Global Biopharmaceutical Cmo & Cro Sales by Application (2015-2020)
5.1.2 Global Biopharmaceutical Cmo & Cro Revenue by Application (2015-2020)
5.1.3 Biopharmaceutical Cmo & Cro Price by Application (2015-2020)
5.2 Biopharmaceutical Cmo & Cro Market Size Forecast by Application (2021-2026)
5.2.1 Global Biopharmaceutical Cmo & Cro Sales Forecast by Application (2021-2026)
5.2.2 Global Biopharmaceutical Cmo & Cro Revenue Forecast by Application (2021-2026)
5.2.3 Global Biopharmaceutical Cmo & Cro Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
6.1.1 United States Biopharmaceutical Cmo & Cro Sales YoY Growth 2015-2026
6.1.2 United States Biopharmaceutical Cmo & Cro Revenue YoY Growth 2015-2026
6.1.3 United States Biopharmaceutical Cmo & Cro Market Share in Global Market 2015-2026
6.2 United States Biopharmaceutical Cmo & Cro Market Size by Players (International and Local Players)
6.2.1 United States Top Biopharmaceutical Cmo & Cro Players by Sales (2015-2020)
6.2.2 United States Top Biopharmaceutical Cmo & Cro Players by Revenue (2015-2020)
6.3 United States Biopharmaceutical Cmo & Cro Historic Market Review by Type (2015-2020)
6.3.1 United States Biopharmaceutical Cmo & Cro Sales Market Share by Type (2015-2020)
6.3.2 United States Biopharmaceutical Cmo & Cro Revenue Market Share by Type (2015-2020)
6.3.3 United States Biopharmaceutical Cmo & Cro Price by Type (2015-2020)
6.4 United States Biopharmaceutical Cmo & Cro Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Biopharmaceutical Cmo & Cro Sales Forecast by Type (2021-2026)
6.4.2 United States Biopharmaceutical Cmo & Cro Revenue Forecast by Type (2021-2026)
6.4.3 United States Biopharmaceutical Cmo & Cro Price Forecast by Type (2021-2026)
6.5 United States Biopharmaceutical Cmo & Cro Historic Market Review by Application (2015-2020)
6.5.1 United States Biopharmaceutical Cmo & Cro Sales Market Share by Application (2015-2020)
6.5.2 United States Biopharmaceutical Cmo & Cro Revenue Market Share by Application (2015-2020)
6.5.3 United States Biopharmaceutical Cmo & Cro Price by Application (2015-2020)
6.6 United States Biopharmaceutical Cmo & Cro Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Biopharmaceutical Cmo & Cro Sales Forecast by Application (2021-2026)
6.6.2 United States Biopharmaceutical Cmo & Cro Revenue Forecast by Application (2021-2026)
6.6.3 United States Biopharmaceutical Cmo & Cro Price Forecast by Application (2021-2026)
7 North America
7.1 North America Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
7.2 North America Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
7.2.1 North America Biopharmaceutical Cmo & Cro Sales by Country (2015-2020)
7.2.2 North America Biopharmaceutical Cmo & Cro Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
8.2 Europe Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
8.2.1 Europe Biopharmaceutical Cmo & Cro Sales by Country
8.2.2 Europe Biopharmaceutical Cmo & Cro Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
9.2 Asia Pacific Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
9.2.1 Asia Pacific Biopharmaceutical Cmo & Cro Sales by Region (2015-2020)
9.2.2 Asia Pacific Biopharmaceutical Cmo & Cro Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
10.2 Latin America Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
10.2.1 Latin America Biopharmaceutical Cmo & Cro Sales by Country
10.2.2 Latin America Biopharmaceutical Cmo & Cro Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biopharmaceutical Cmo & Cro Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Biopharmaceutical Cmo & Cro Market Facts & Figures by Country
11.2.1 Middle East and Africa Biopharmaceutical Cmo & Cro Sales by Country
11.2.2 Middle East and Africa Biopharmaceutical Cmo & Cro Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Lonza
12.1.1 Lonza Corporation Information
12.1.2 Lonza Description and Business Overview
12.1.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Lonza Biopharmaceutical Cmo & Cro Products Offered
12.1.5 Lonza Recent Development
12.2 Boehringer Ingelheim GmbH
12.2.1 Boehringer Ingelheim GmbH Corporation Information
12.2.2 Boehringer Ingelheim GmbH Description and Business Overview
12.2.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Products Offered
12.2.5 Boehringer Ingelheim GmbH Recent Development
12.3 Rentschler Biotechnologie GmbH
12.3.1 Rentschler Biotechnologie GmbH Corporation Information
12.3.2 Rentschler Biotechnologie GmbH Description and Business Overview
12.3.3 Rentschler Biotechnologie GmbH Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Products Offered
12.3.5 Rentschler Biotechnologie GmbH Recent Development
12.4 Inno Biologics Sdn Bhd
12.4.1 Inno Biologics Sdn Bhd Corporation Information
12.4.2 Inno Biologics Sdn Bhd Description and Business Overview
12.4.3 Inno Biologics Sdn Bhd Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Products Offered
12.4.5 Inno Biologics Sdn Bhd Recent Development
12.5 JRS Pharma (Celonic GmbH)
12.5.1 JRS Pharma (Celonic GmbH) Corporation Information
12.5.2 JRS Pharma (Celonic GmbH) Description and Business Overview
12.5.3 JRS Pharma (Celonic GmbH) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Products Offered
12.5.5 JRS Pharma (Celonic GmbH) Recent Development
12.6 BIOMEVA GmbH
12.6.1 BIOMEVA GmbH Corporation Information
12.6.2 BIOMEVA GmbH Description and Business Overview
12.6.3 BIOMEVA GmbH Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BIOMEVA GmbH Biopharmaceutical Cmo & Cro Products Offered
12.6.5 BIOMEVA GmbH Recent Development
12.7 ProBioGen
12.7.1 ProBioGen Corporation Information
12.7.2 ProBioGen Description and Business Overview
12.7.3 ProBioGen Sales, Revenue and Gross Margin (2015-2020)
12.7.4 ProBioGen Biopharmaceutical Cmo & Cro Products Offered
12.7.5 ProBioGen Recent Development
12.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
12.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Corporation Information
12.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Description and Business Overview
12.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Products Offered
12.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
12.9 TOYOBO CO., LTD
12.9.1 TOYOBO CO., LTD Corporation Information
12.9.2 TOYOBO CO., LTD Description and Business Overview
12.9.3 TOYOBO CO., LTD Sales, Revenue and Gross Margin (2015-2020)
12.9.4 TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Products Offered
12.9.5 TOYOBO CO., LTD Recent Development
12.10 Samsung BioLogics
12.10.1 Samsung BioLogics Corporation Information
12.10.2 Samsung BioLogics Description and Business Overview
12.10.3 Samsung BioLogics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Samsung BioLogics Biopharmaceutical Cmo & Cro Products Offered
12.10.5 Samsung BioLogics Recent Development
12.11 Lonza
12.11.1 Lonza Corporation Information
12.11.2 Lonza Description and Business Overview
12.11.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Lonza Biopharmaceutical Cmo & Cro Products Offered
12.11.5 Lonza Recent Development
12.12 CMC Biologics
12.12.1 CMC Biologics Corporation Information
12.12.2 CMC Biologics Description and Business Overview
12.12.3 CMC Biologics Sales, Revenue and Gross Margin (2015-2020)
12.12.4 CMC Biologics Products Offered
12.12.5 CMC Biologics Recent Development
12.13 Binex Co., Ltd.
12.13.1 Binex Co., Ltd. Corporation Information
12.13.2 Binex Co., Ltd. Description and Business Overview
12.13.3 Binex Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Binex Co., Ltd. Products Offered
12.13.5 Binex Co., Ltd. Recent Development
12.14 AbbVie Inc.
12.14.1 AbbVie Inc. Corporation Information
12.14.2 AbbVie Inc. Description and Business Overview
12.14.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
12.14.4 AbbVie Inc. Products Offered
12.14.5 AbbVie Inc. Recent Development
12.15 WuXi Biologics.
12.15.1 WuXi Biologics. Corporation Information
12.15.2 WuXi Biologics. Description and Business Overview
12.15.3 WuXi Biologics. Sales, Revenue and Gross Margin (2015-2020)
12.15.4 WuXi Biologics. Products Offered
12.15.5 WuXi Biologics. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Biopharmaceutical Cmo & Cro Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biopharmaceutical Cmo & Cro Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Biopharmaceutical Cmo & Cro Market Segments
Table 2. Ranking of Global Top Biopharmaceutical Cmo & Cro Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biopharmaceutical Cmo & Cro Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Biologics
Table 5. Major Manufacturers of Biosimilars
Table 6. Global Biopharmaceutical Cmo & Cro Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Biopharmaceutical Cmo & Cro Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Biopharmaceutical Cmo & Cro Sales by Regions 2015-2020 (K MT)
Table 9. Global Biopharmaceutical Cmo & Cro Sales Market Share by Regions (2015-2020)
Table 10. Global Biopharmaceutical Cmo & Cro Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Biopharmaceutical Cmo & Cro Sales Forecast by Region (2021-2026) (K MT)
Table 12. Global Biopharmaceutical Cmo & Cro Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Biopharmaceutical Cmo & Cro Sales Share by Manufacturers (2015-2020)
Table 14. Global Biopharmaceutical Cmo & Cro Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Biopharmaceutical Cmo & Cro by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Cmo & Cro as of 2019)
Table 16. Biopharmaceutical Cmo & Cro Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Biopharmaceutical Cmo & Cro Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Biopharmaceutical Cmo & Cro Price (2015-2020) (USD/MT)
Table 19. Biopharmaceutical Cmo & Cro Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Biopharmaceutical Cmo & Cro Product Type
Table 21. Date of International Manufacturers Enter into Biopharmaceutical Cmo & Cro Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical Cmo & Cro Sales by Type (2015-2020) (K MT)
Table 24. Global Biopharmaceutical Cmo & Cro Sales Share by Type (2015-2020)
Table 25. Global Biopharmaceutical Cmo & Cro Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Biopharmaceutical Cmo & Cro Revenue Share by Type (2015-2020)
Table 27. Biopharmaceutical Cmo & Cro Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Biopharmaceutical Cmo & Cro Sales Share by Type (2021-2026)
Table 29. Global Biopharmaceutical Cmo & Cro Sales by Application (2015-2020) (K MT)
Table 30. Global Biopharmaceutical Cmo & Cro Sales Share by Application (2015-2020)
Table 31. Global Biopharmaceutical Cmo & Cro Sales Share by Application (2021-2026)
Table 32. Global Biopharmaceutical Cmo & Cro Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Biopharmaceutical Cmo & Cro Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Biopharmaceutical Cmo & Cro Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Biopharmaceutical Cmo & Cro Sales (K MT) of Key Companies (2015-2020)
Table 36. United States Biopharmaceutical Cmo & Cro Sales Share by Company (2015-2020)
Table 37. United States Biopharmaceutical Cmo & Cro Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Biopharmaceutical Cmo & Cro Sales (K MT) by Type (2015-2020)
Table 39. United States Biopharmaceutical Cmo & Cro Sales Share by Type (2015-2020)
Table 40. United States Biopharmaceutical Cmo & Cro Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Biopharmaceutical Cmo & Cro Price (K MT) by Type (2015-2020)
Table 42. United States Biopharmaceutical Cmo & Cro Sales (K MT) by Type (2021-2026)
Table 43. United States Biopharmaceutical Cmo & Cro Sales Share by Type (2021-2026)
Table 44. United States Biopharmaceutical Cmo & Cro Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Biopharmaceutical Cmo & Cro Revenue Share by Type (2021-2026)
Table 46. United States Biopharmaceutical Cmo & Cro Price (K MT) by Type (2021-2026)
Table 47. United States Biopharmaceutical Cmo & Cro Sales (K MT) by Application (2015-2020)
Table 48. United States Biopharmaceutical Cmo & Cro Sales Share by Application (2015-2020)
Table 49. United States Biopharmaceutical Cmo & Cro Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Biopharmaceutical Cmo & Cro Sales (K MT) by Application (2021-2026)
Table 51. United States Biopharmaceutical Cmo & Cro Sales Share by Application (2021-2026)
Table 52. United States Biopharmaceutical Cmo & Cro Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Biopharmaceutical Cmo & Cro Revenue Share by Application (2021-2026)
Table 54. North America Biopharmaceutical Cmo & Cro Sales by Country (2015-2020) (K MT)
Table 55. North America Biopharmaceutical Cmo & Cro Sales Market Share by Country (2015-2020)
Table 56. North America Biopharmaceutical Cmo & Cro Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Biopharmaceutical Cmo & Cro Revenue Market Share by Country (2015-2020)
Table 58. Europe Biopharmaceutical Cmo & Cro Sales by Country (2015-2020) (K MT)
Table 59. Europe Biopharmaceutical Cmo & Cro Sales Market Share by Country (2015-2020)
Table 60. Europe Biopharmaceutical Cmo & Cro Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Biopharmaceutical Cmo & Cro Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Biopharmaceutical Cmo & Cro Sales by Region (2015-2020) (K MT)
Table 63. Asia Pacific Biopharmaceutical Cmo & Cro Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Biopharmaceutical Cmo & Cro Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Biopharmaceutical Cmo & Cro Revenue Market Share by Region (2015-2020)
Table 66. Latin America Biopharmaceutical Cmo & Cro Sales by Country (2015-2020) (K MT)
Table 67. Latin America Biopharmaceutical Cmo & Cro Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Biopharmaceutical Cmo & Cro Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Biopharmaceutical Cmo & Cro Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Biopharmaceutical Cmo & Cro Sales by Country (2015-2020) (K MT)
Table 71. Middle East and Africa Biopharmaceutical Cmo & Cro Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Biopharmaceutical Cmo & Cro Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Biopharmaceutical Cmo & Cro Revenue Market Share by Country (2015-2020)
Table 74. Lonza Corporation Information
Table 75. Lonza Description and Business Overview
Table 76. Lonza Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Lonza Biopharmaceutical Cmo & Cro Product
Table 78. Lonza Recent Development
Table 79. Boehringer Ingelheim GmbH Corporation Information
Table 80. Boehringer Ingelheim GmbH Description and Business Overview
Table 81. Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Boehringer Ingelheim GmbH Product
Table 83. Boehringer Ingelheim GmbH Recent Development
Table 84. Rentschler Biotechnologie GmbH Corporation Information
Table 85. Rentschler Biotechnologie GmbH Description and Business Overview
Table 86. Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Rentschler Biotechnologie GmbH Product
Table 88. Rentschler Biotechnologie GmbH Recent Development
Table 89. Inno Biologics Sdn Bhd Corporation Information
Table 90. Inno Biologics Sdn Bhd Description and Business Overview
Table 91. Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Inno Biologics Sdn Bhd Product
Table 93. Inno Biologics Sdn Bhd Recent Development
Table 94. JRS Pharma (Celonic GmbH) Corporation Information
Table 95. JRS Pharma (Celonic GmbH) Description and Business Overview
Table 96. JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. JRS Pharma (Celonic GmbH) Product
Table 98. JRS Pharma (Celonic GmbH) Recent Development
Table 99. BIOMEVA GmbH Corporation Information
Table 100. BIOMEVA GmbH Description and Business Overview
Table 101. BIOMEVA GmbH Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. BIOMEVA GmbH Product
Table 103. BIOMEVA GmbH Recent Development
Table 104. ProBioGen Corporation Information
Table 105. ProBioGen Description and Business Overview
Table 106. ProBioGen Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. ProBioGen Product
Table 108. ProBioGen Recent Development
Table 109. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Corporation Information
Table 110. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Description and Business Overview
Table 111. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Product
Table 113. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
Table 114. TOYOBO CO., LTD Corporation Information
Table 115. TOYOBO CO., LTD Description and Business Overview
Table 116. TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. TOYOBO CO., LTD Product
Table 118. TOYOBO CO., LTD Recent Development
Table 119. Samsung BioLogics Corporation Information
Table 120. Samsung BioLogics Description and Business Overview
Table 121. Samsung BioLogics Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Samsung BioLogics Product
Table 123. Samsung BioLogics Recent Development
Table 124. Patheon Corporation Information
Table 125. Patheon Description and Business Overview
Table 126. Patheon Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Patheon Product
Table 128. Patheon Recent Development
Table 129. CMC Biologics Corporation Information
Table 130. CMC Biologics Description and Business Overview
Table 131. CMC Biologics Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. CMC Biologics Product
Table 133. CMC Biologics Recent Development
Table 134. Binex Co., Ltd. Corporation Information
Table 135. Binex Co., Ltd. Description and Business Overview
Table 136. Binex Co., Ltd. Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Binex Co., Ltd. Product
Table 138. Binex Co., Ltd. Recent Development
Table 139. AbbVie Inc. Corporation Information
Table 140. AbbVie Inc. Description and Business Overview
Table 141. AbbVie Inc. Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. AbbVie Inc. Product
Table 143. AbbVie Inc. Recent Development
Table 144. WuXi Biologics. Corporation Information
Table 145. WuXi Biologics. Description and Business Overview
Table 146. WuXi Biologics. Biopharmaceutical Cmo & Cro Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. WuXi Biologics. Product
Table 148. WuXi Biologics. Recent Development
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Biopharmaceutical Cmo & Cro Players
Table 153. Biopharmaceutical Cmo & Cro Customers List
Table 154. Biopharmaceutical Cmo & Cro Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceutical Cmo & Cro Product Picture
Figure 2. Global Biopharmaceutical Cmo & Cro Sales Market Share by Type in 2020 & 2026
Figure 3. Biologics Product Picture
Figure 4. Biosimilars Product Picture
Figure 5. Global Biopharmaceutical Cmo & Cro Sales Market Share by Application in 2020 & 2026
Figure 6. Contract Manufacturing
Figure 7. Contract Research
Figure 8. Biopharmaceutical Cmo & Cro Report Years Considered
Figure 9. Global Biopharmaceutical Cmo & Cro Market Size 2015-2026 (US$ Million)
Figure 10. Global Biopharmaceutical Cmo & Cro Sales 2015-2026 (K MT)
Figure 11. Global Biopharmaceutical Cmo & Cro Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Biopharmaceutical Cmo & Cro Sales Market Share by Region (2015-2020)
Figure 13. Global Biopharmaceutical Cmo & Cro Sales Market Share by Region in 2019
Figure 14. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Region (2015-2020)
Figure 15. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Region in 2019
Figure 16. Global Biopharmaceutical Cmo & Cro Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical Cmo & Cro Revenue in 2019
Figure 18. Biopharmaceutical Cmo & Cro Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Biopharmaceutical Cmo & Cro Sales Market Share by Type (2015-2020)
Figure 20. Global Biopharmaceutical Cmo & Cro Sales Market Share by Type in 2019
Figure 21. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Type (2015-2020)
Figure 22. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Type in 2019
Figure 23. Global Biopharmaceutical Cmo & Cro Market Share by Price Range (2015-2020)
Figure 24. Global Biopharmaceutical Cmo & Cro Sales Market Share by Application (2015-2020)
Figure 25. Global Biopharmaceutical Cmo & Cro Sales Market Share by Application in 2019
Figure 26. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Application (2015-2020)
Figure 27. Global Biopharmaceutical Cmo & Cro Revenue Market Share by Application in 2019
Figure 28. United States Biopharmaceutical Cmo & Cro Sales Growth Rate 2015-2026 (K MT)
Figure 29. United States Biopharmaceutical Cmo & Cro Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. United States Biopharmaceutical Cmo & Cro Market Share in Global Market 2015-2026
Figure 31. United States 5 and 10 Largest Biopharmaceutical Cmo & Cro Players Market Share by Revenue in Biopharmaceutical Cmo & Cro in 2019
Figure 32. United States Biopharmaceutical Cmo & Cro Revenue Share by Type (2015-2020)
Figure 33. United States Biopharmaceutical Cmo & Cro Revenue Growth Rate by Type in 2015 & 2019
Figure 34. United States Biopharmaceutical Cmo & Cro Revenue Share by Application (2015-2020)
Figure 35. United States Biopharmaceutical Cmo & Cro Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Biopharmaceutical Cmo & Cro Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America Biopharmaceutical Cmo & Cro Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Biopharmaceutical Cmo & Cro Sales Market Share by Country in 2019
Figure 39. North America Biopharmaceutical Cmo & Cro Revenue Market Share by Country in 2019
Figure 40. U.S. Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Biopharmaceutical Cmo & Cro Sales Growth Rate 2015-2020 (K MT)
Figure 45. Europe Biopharmaceutical Cmo & Cro Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Biopharmaceutical Cmo & Cro Sales Market Share by Country in 2019
Figure 47. Europe Biopharmaceutical Cmo & Cro Revenue Market Share by Country in 2019
Figure 48. Germany Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 49. Germany Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 51. France Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 53. U.K. Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 55. Italy Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 57. Russia Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Asia Pacific Biopharmaceutical Cmo & Cro Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Biopharmaceutical Cmo & Cro Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Biopharmaceutical Cmo & Cro Sales Market Share by Region in 2019
Figure 61. Asia Pacific Biopharmaceutical Cmo & Cro Revenue Market Share by Region in 2019
Figure 62. China Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Biopharmaceutical Cmo & Cro Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Biopharmaceutical Cmo & Cro Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Biopharmace
  • Dextran - Global Market Insights and Sales Trends 2024 -2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 122
    The global Dextran market was valued at US$ 234.14 million in 2022 and it will reach US$ 346.64 million by the end of 2029, growing at a CAGR of 5.97% during 2023-2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Dextran, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed bu......
  • Global Corticosteroids API Market Research Report 2023
    Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 162
    The global Corticosteroids API market was valued at US$ 2206.26 million in 2022 and is anticipated to reach US$ 3309.40 million by 2029, witnessing a CAGR of 6.11% during the forecast period 2023-2029. North American market for Corticosteroids API is estimated to increase from $ 220.53 million in 2022 to reach $ 302.18 million by 2029, at a CAGR of 4.69 % during the forecast period of 2023 through 2029. Europe market for Corticosteroids API is estimated to increase from $ 512.79 mi......
  • Global HPLC Columns Market Research Report 2023
    Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 149
    The global HPLC Columns market was valued at US$ 1823.16 million in 2022 and is anticipated to reach US$ 2674.78 million by 2029, witnessing a CAGR of 6.37% during the forecast period 2023-2029. The major global manufacturers of HPLC Columns include Agilent, Waters Corporation, Shimadzu, Thermo Fisher Scientific, Danaher, Hamilton, Merck, Bio - Rad, and Restek, etc. In 2022, the world's top three vendors accounted for approximately 48.41 % of the revenue. Report Scope This r......
  • Global Inorganic Advanced Phase Change Materials Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Inorganic Advanced Phase Change Materials market was valued at US$ 960.3 million in 2023 and is anticipated to reach US$ 2087.3 million by 2030, witnessing a CAGR of 11.9% during The forecast period 2024-2030. North American market for Inorganic Advanced Phase Change Materials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Inorganic Advanced Phase Ch......
  • Global Material Jetting 3D Printing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The global Material Jetting 3D Printing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Material Jetting 3D Printing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Material Jetting 3D Printing is estimated to increase from $ million i......
  • Global Halogen Free Material Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 81
    The global Halogen Free Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Silicone Adhesives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 101
    The global Silicone Adhesives market was valued at US$ 1999.8 million in 2023 and is anticipated to reach US$ 2628.8 million by 2030, witnessing a CAGR of 3.5% during The forecast period 2024-2030. North American market for Silicone Adhesives is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Silicone Adhesives is estimated to increase from $ million in 2023 to rea......
  • Global Paraffin Hydrotreating Catalyst Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 91
    The global Paraffin Hydrotreating Catalyst market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Paraffin Hydrotreating Catalyst is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Paraffin Hydrotreating Catalyst is estimated to increase from $ ......
  • Global Stained Glass Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Stained Glass market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs